186 related articles for article (PubMed ID: 10076569)
1. Low glutathione and glutathione S-transferase levels in Barrett's esophagus as compared to normal esophageal epithelium.
van Lieshout EM; Tiemessen DM; Witteman BJ; Jansen JB; Peters WH
Jpn J Cancer Res; 1999 Jan; 90(1):81-5. PubMed ID: 10076569
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of glutathione S-transferase alpha and pi in human esophageal squamous epithelium, Barrett's epithelium and carcinoma.
van Lieshout EM; van Haelst UJ; Wobbes T; Peters WH
Jpn J Cancer Res; 1999 May; 90(5):530-5. PubMed ID: 10391093
[TBL] [Abstract][Full Text] [Related]
3. Glutathione and glutathione S-transferases in Barrett's epithelium.
Peters WH; Roelofs HM; Hectors MP; Nagengast FM; Jansen JB
Br J Cancer; 1993 Jun; 67(6):1413-7. PubMed ID: 8512826
[TBL] [Abstract][Full Text] [Related]
4. Glutathione S-transferase-pi expression is downregulated in patients with Barrett's esophagus and esophageal adenocarcinoma.
Brabender J; Lord RV; Wickramasinghe K; Metzger R; Schneider PM; Park JM; Hölscher AH; DeMeester TR; Danenberg KD; Danenberg PV
J Gastrointest Surg; 2002; 6(3):359-67. PubMed ID: 12022988
[TBL] [Abstract][Full Text] [Related]
5. Alteration of glutathione S-transferase levels in Barrett's metaplasia compared to normal oesophageal epithelium.
Cobbe SC; Scobie GC; Pohler E; Hayes JD; Kernohan NM; Dillon JF
Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):41-7. PubMed ID: 12544693
[TBL] [Abstract][Full Text] [Related]
6. Induction of glutathione s-transferase-pi in Barrett's metaplasia and Barrett's adenocarcinoma cell lines.
Compton KR; Orringer MB; Beer DG
Mol Carcinog; 1999 Feb; 24(2):128-36. PubMed ID: 10078940
[TBL] [Abstract][Full Text] [Related]
7. Expression of glutathione s-transferase pi in benign mucosa, Barrett's metaplasia, and adenocarcinoma of the esophagus.
Chandra RK; Bentz BG; Haines GK; Robinson AM; Radosevich JA
Head Neck; 2002 Jun; 24(6):575-81. PubMed ID: 12112555
[TBL] [Abstract][Full Text] [Related]
8. Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barrett's esophagus and esophageal carcinoma.
van Lieshout EM; Roelofs HM; Dekker S; Mulder CJ; Wobbes T; Jansen JB; Peters WH
Cancer Res; 1999 Feb; 59(3):586-9. PubMed ID: 9973204
[TBL] [Abstract][Full Text] [Related]
9. Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis.
Herszenyi L; Hritz I; Pregun I; Sipos F; Juhasz M; Molnar B; Tulassay Z
World J Gastroenterol; 2007 Feb; 13(5):676-82. PubMed ID: 17278189
[TBL] [Abstract][Full Text] [Related]
10. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.
Wang DH; Clemons NJ; Miyashita T; Dupuy AJ; Zhang W; Szczepny A; Corcoran-Schwartz IM; Wilburn DL; Montgomery EA; Wang JS; Jenkins NA; Copeland NA; Harmon JW; Phillips WA; Watkins DN
Gastroenterology; 2010 May; 138(5):1810-22. PubMed ID: 20138038
[TBL] [Abstract][Full Text] [Related]
11. Pathology of Barrett's esophagus by proton magnetic resonance spectroscopy and a statistical classification strategy.
Doran ST; Falk GL; Somorjai RL; Lean CL; Himmelreich U; Philips J; Russell P; Dolenko B; Nikulin AE; Mountford CE
Am J Surg; 2003 Mar; 185(3):232-8. PubMed ID: 12620562
[TBL] [Abstract][Full Text] [Related]
12. The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study.
Buttar NS; Wang KK; Anderson MA; Dierkhising RA; Pacifico RJ; Krishnadath KK; Lutzke LS
J Natl Cancer Inst; 2002 Mar; 94(6):422-9. PubMed ID: 11904314
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 expression in esophageal epithelium before and after photodynamic therapy for Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.
Yachimski P; Mino-Kenudson M; Sherwood ME; Puricelli WP; Nishioka NS; Lauwers GY
Virchows Arch; 2011 Dec; 459(6):581-6. PubMed ID: 22081106
[TBL] [Abstract][Full Text] [Related]
14. Expression profile and cellular localizations of mucin proteins, CK7, and cytoplasmic p27 in Barrett's esophagus and esophageal adenocarcinoma.
Ozcan HEA; Anuk T; Ozden O
Adv Med Sci; 2018 Sep; 63(2):296-300. PubMed ID: 29803118
[TBL] [Abstract][Full Text] [Related]
15. ErbB2 without erbB3 expression in metaplastic columnar epithelium of Barrett's esophagus.
Nishigaki H; Wada K; Tatsuguchi A; Sueoka N; Futagami S; Gudis K; Miyake K; Tsukui T; Sakamoto C
Digestion; 2004; 70(2):95-102. PubMed ID: 15375338
[TBL] [Abstract][Full Text] [Related]
16. Age and gender dependent levels of glutathione and glutathione S-transferases in human lymphocytes.
van Lieshout EM; Peters WH
Carcinogenesis; 1998 Oct; 19(10):1873-5. PubMed ID: 9806172
[TBL] [Abstract][Full Text] [Related]
17. Toll-like Receptor 2 Signalling and the Lysosomal Machinery in Barrett's Esophagus.
Verbeek RE; Siersema PD; Vleggaar FP; Ten Kate FJ; Posthuma G; Souza RF; de Haan J; van Baal JW
J Gastrointestin Liver Dis; 2016 Sep; 25(3):273-82. PubMed ID: 27689189
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.
Sreedharan L; Mayne GC; Watson DI; Bright T; Lord RV; Ansar A; Wang T; Kist J; Astill DS; Hussey DJ
World J Gastroenterol; 2017 Aug; 23(30):5508-5518. PubMed ID: 28852310
[TBL] [Abstract][Full Text] [Related]
19. Expression of the putative stem cell marker Musashi-1 in Barrett's esophagus and esophageal adenocarcinoma.
Bobryshev YV; Freeman AK; Botelho NK; Tran D; Levert-Mignon AJ; Lord RV
Dis Esophagus; 2010 Sep; 23(7):580-9. PubMed ID: 20459440
[TBL] [Abstract][Full Text] [Related]
20. Survivin, a potential biomarker in the development of Barrett's adenocarcinoma.
Vallböhmer D; Peters JH; Oh D; Kuramochi H; Shimizu D; Demeester SR; Hagen JA; Chandrasoma PT; Danenberg KD; DeMeester TR; Danenberg P
Surgery; 2005 Oct; 138(4):701-6; discussion 706-7. PubMed ID: 16269299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]